
    
      The study is meant to give a better understanding of the basic mechanisms behind migraine,
      and a better understanding of the effects of sumatriptan on the trigemino vascular system.

      The endpoints are changes in the plasma values of the neuropeptides vasoactive intestinal
      polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase
      activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.
    
  